Every Form 4 that Texas Capital Bancshares, Inc. (TCBIO) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow TCBIO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TCBIO filings page.
Texas Capital Bancshares Inc. director-related entity reports preferred share purchase. On 01/23/2026, SCG Ventures LP, an entity associated with director Robert W. Stallings, purchased 2,000 Depositary Shares for Series B Preferred Stock at an average price of $20.91 per depositary share. Each depositary share represents a 1/40th interest in a share of the company’s 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B.
After this transaction, SCG Ventures LP is shown as indirectly holding 277,913 depositary shares and 90,039 shares of common stock. Separately, the Stallings Foundation, a charitable foundation where Mr. Stallings is an officer, is listed with 60,000 depositary shares. Direct holdings are also reported at 84,587 depositary shares and 289,961 common shares.
Texas Capital Bancshares director Laura L. Whitley reported open-market purchases of the company’s common stock. On January 23, 2026, she bought 500 shares at a price of $97.56 per share. She then purchased another 500 shares on January 26, 2026 at $97.51 per share. Following these transactions, Whitley directly owned 7,961 shares of Texas Capital Bancshares common stock.